Toward the end of trading Thursday, the Dow traded up 0.52% to 33,995.76 while the NASDAQ rose 0.13% to 14,069.67. The S&P also rose, gaining 0.50% to 4,204.22.
The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,230,800 cases with around 574,330 deaths. India confirmed a total of at least 18,376,420 cases and 204,830 deaths, while Brazil reported over 14,521,280 COVID-19 cases with 398,180 deaths. In total, there were at least 149,718,850 cases of COVID-19 worldwide with more than 3,153,410 deaths, according to data compiled by Johns Hopkins University.
Leading and Lagging Sectors
Communication services shares climbed by 2.2% on Thursday. Meanwhile, top gainers in the sector included DISH Network Corporation DISH, up 8%, and Facebook, Inc. FB, up 6%.
In trading on Thursday, health care shares fell 0.7%.
Top Headline
McDonald's Corporation MCD reported better-than-expected results for its first quarter.
McDonald's reported revenue of $5.13 billion in the first quarter, beating estimates of $5.03 billion. Earnings per share of $1.91 beat estimates of $1.81. The company’s Q1 global comps rose 7.5% year over year.
Equities Trading UP
JAKKS Pacific, Inc. JAKK shares shot up 20% to $8.82 after the company reported better-than-expected Q1 results.
Shares of Galera Therapeutics, Inc. GRTX got a boost, shooting 23% to $8.15 after the company announced updated results from its Phase 1/2 pilot trial of GC4419, versus placebo, in patients with locally advanced pancreatic cancer who are undergoing stereotactic body radiation therapy.
ShiftPixy, Inc. PIXY shares were also up, gaining 14% to $2.85 as the company said it has been named as sponsor related to 4 SPACs.
Check out these big movers of the day
Equities Trading DOWN
Adverum Biotechnologies, Inc. ADVM shares tumbled 61% to $3.99 after the company announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
Shares of Cara Therapeutics, Inc. CARA were down 46% to $14.01 after the company announced mixed topline results from its KARE Phase 2 dose-ranging clinical trial of oral Korsuva for the treatment of moderate-to-severe pruritus in mild-to-severe atopic dermatitis patients. The company said the study did not meet the primary endpoint of worst-itch NRS change from baseline at week 12 or secondary endpoint of 4-point responder analysis in the intent-to-treat patient population. However, the study achieved primary endpoint of worst-itch NRS change and secondary endpoint of 4-point responder analysis in pre-specified analyses of mild-to-moderate AD patients, comprising 64% of ITT population.
Farmmi, Inc. FAMI was down, falling 56% to $0.3484 after the company priced its $42.0 million upsized underwritten public offering of ordinary shares.
Commodities
In commodity news, oil traded up 1.6% to $64.89, while gold traded down 0.3% to $1,768.10.
Silver traded down 0.2% Thursday to $26.045 while copper fell 0.4% to $4.4790.
Euro zone
European shares closed mostly lower today. The eurozone’s STOXX 600 fell 0.26%, the Spanish Ibex Index rose 0.27% and the German DAX 30 dropped 0.9%. Meanwhile, the French CAC 40 fell 0.07% London’s FTSE 100 fell 0.03% and Italy’s FTSE MIB dropped 0.74%.
UK car production surged 46.6% year-over-year to 115,498 units in March. Annual inflation rate in Spain increased to 2.2% in April from 1.3% in the prior month, while unemployment rate dropped to 15.98% in the first quarter from 16.13%. Import prices in Germany increased 6.9% year-over-year in March, while unemployment rate came in unchanged at 4.5% in March.
Economics
The US economy expanded by an annualized 6.4% in the first quarter, versus a 4.3% increase in the prior three-month period.
US initial jobless claims fell to 553 thousand in the week ended April 24th from a revised reading of 566 thousand in the prior week.
US pending home sales index rose 1.9% for March.
US natural gas supplies rose 15 billion cubic feet last week, the Energy Information Administration said.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
